IntroGene: Over the manufacturing hurdle
Netherlands Emerging Company Profile
One of the roadblocks to development of adenovirus and adeno-associated virus as gene therapy vectors has been manufacturing. For adenovirus, the problem has been difficulty in manufacturing vectors free from contamination by replication-competent adenovirus. For adeno-associated virus, the issue has been the lack of a stable packaging cell line.
One company that believes it has solved the problems is